Furthermore, Benchmark expects that Texas Instruments (NASDAQ:TXN) will leverage its supply and capacity strengths as its core markets begin to align shipments with consumption levels later in the year. The company maintains strong financial flexibility with a healthy current ratio of 4.31 and has impressively maintained dividend payments for 55 consecutive years. In light of these factors, Benchmark has reiterated its Buy rating and maintains a $230 price target on Texas Instruments shares. This target is based on 35 times the firm's new FY26 earnings per share (EPS) estimate of $6.53, equating to a price/earnings to growth (PEG) ratio of just 1.26 times the projected FY26 EPS growth rate of 28%. For deeper insights into TXN's valuation and growth prospects, investors can access comprehensive analysis through InvestingPro's detailed research reports, which cover over 1,400 US stocks.
Furthermore, Benchmark expects that Texas Instruments will leverage its supply and capacity strengths as its core markets begin to align shipments with consumption levels later in the year. The company maintains strong financial flexibility with a healthy current ratio of 4.31 and has impressively maintained dividend payments for 55 consecutive years. In light of these factors, Benchmark has reiterated its Buy rating and maintains a $230 price target on Texas Instruments shares. This target is based on 35 times the firm's new FY26 earnings per share (EPS) estimate of $6.53, equating to a price/earnings to growth (PEG) ratio of just 1.26 times the projected FY26 EPS growth rate of 28%. For deeper insights into TXN's valuation and growth prospects, investors can access comprehensive analysis through InvestingPro's detailed research reports, which cover over 1,400 US stocks.
The analysts highlighted Texas Instruments' high internal inventory levels as a strategic advantage. This inventory is expected to enable the company to aggressively compete for market share in areas it previously had to forgo due to supply constraints brought about by the COVID-19 pandemic. The analysts anticipate that this will bolster the momentum Texas Instruments is currently experiencing in its non-Automotive and Industrial sectors.
Furthermore, Benchmark expects that Texas Instruments will leverage its supply and capacity strengths as its core markets begin to align shipments with consumption levels later in the year. The company maintains strong financial flexibility with a healthy current ratio of 4.31 and has impressively maintained dividend payments for 55 consecutive years. In light of these factors, Benchmark has reiterated its Buy rating and maintains a $230 price target on Texas Instruments shares. This target is based on 35 times the firm's new FY26 earnings per share (EPS) estimate of $6.53, equating to a price/earnings to growth (PEG) ratio of just 1.26 times the projected FY26 EPS growth rate of 28%. For deeper insights into TXN's valuation and growth prospects, investors can access comprehensive analysis through InvestingPro's detailed research reports, which cover over 1,400 US stocks.
In other recent news, Texas Instruments, a semiconductor giant, has been the subject of various analyst reviews. The company reported a revenue of $4.00 billion, a 4.1% increase from Stifel's estimate, mainly driven by the Personal Electronics sector. However, the Industrial and Automotive sectors did not perform as well. Stifel maintains a hold rating on Texas Instruments with a steady price target of $200.00.
Truist Securities adjusted the price target for Texas Instruments from $199.00 to $195.00, while maintaining a Hold rating. They cited concerns in the semiconductor industry, particularly in the industrial and automotive markets. Cantor Fitzgerald and Mizuho (NYSE:MFG) Securities also maintain neutral ratings on the company with price targets of $200 and $190, respectively.
Citi analyst Christopher Danely maintains a buy rating on Texas Instruments, albeit with a reduced price target of $284. Danely's reassessment is based on the expectation that Texas Instruments is poised for a period of upward revisions over the next 4 to 6 quarters. These recent developments indicate a mixed outlook for Texas Instruments among different analyst firms.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.